Disruption comes for Cancer

Emily HempelPress

An influential operative in the life sciences area – and this is relevant because we are expanding holdings in drug companies Eli Lilly and Moderna in the portfolios we manage – … Read More

May 2026 Update+

Emily HempelUpdatePlus, Press, Disruption

Welcome to Update+, a short tour around the grounds of investment in the big disruptive trends that are driving business. This month, Investment Analyst Tom Keir discusses the rise and fall … Read More